Ranbaxy shares fall after settlement with Pfizer

June 19th, 2008 - 9:44 pm ICT by IANS  


Mumbai, June 19 (IANS) The share price of India’s leading drugmaker Ranbaxy Laboratories fell by nearly eight percent following the settlement with Pfizer on a patent dispute. The stock ended down 7.68 percent at the Bombay Stock Exchange at Rs.598.20 after touching a low of Rs.548.10 and a high of Rs.613.70.

On Wednesday, Pfizer said Ranbaxy can start selling a US generic form of its cholesterol drug Lipitor by late 2011.

Tags: , , , , , , , , , , ,

Posted in Business |

Subscribe